EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Acute unilateral vestibulopathy and corticosteroid treatment - A randomized placebo-controlled double-blind trial

Julia Sjögren iD, Per-Anders Fransson, Måns Magnusson iD, Mikael Karlberg, Fredrik Tjernström iD

Journal of Vestibular Research · 2025

DOI: 10.1177/09574271241307649 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vestibular Research, 2025. Verfasst von Julia Sjögren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Otorhinolaryngology Head and Neck Surgery, Skåne University Hospital, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Vestibular Neuronitis, Betamethasone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish governmental clinical research, regional research support for clinical trials, Nils Gunnar Henrikssons fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The efficacy of corticosteroids for treating acute vestibular neuritis, or acute unilateral vestibulopathy (AUVP), remains controversial.

Objective

This study aimed to evaluate whether corticosteroids improve vestibular function and reduce symptoms in both acute and chronic phases of AUVP.

Methods

This randomized, placebo-controlled, double-blind trial included patients with AUVP (ages 18–80) from emergency departments at three sites in southern Sweden. Patients were randomly assigned to one of three groups: placebo, 3-day or 10-day corticosteroid treatment. The steroid groups received intravenous betamethasone followed by oral steroids, while the placebo group received intravenous saline followed by oral placebo. The primary outcome was canal paresis (%) after 12 months, measured via caloric testing. Secondary outcomes included vHIT gain, Diary Vertigo score, Dizziness Handicap Inventory, and Hospital Anxiety and Depression Scale. Analyses were conducted on an intention-to-treat basis. The trial was registered with the EU Clinical Trials Register (EudraCT Number: 2014-005484-32) and ClinicalTrials.gov (NCT00802529).

Results

From December 2015 to March 2021, 350 patients were screened, and 69 were included: 23 in the 10-day corticosteroid group, 22 in the 3-day corticosteroid group, and 24 in the placebo group. All groups showed significant improvement in caloric function over time ( p = .002), with no significant differences between groups at any time point ( p = .629). Change in caloric asymmetry from baseline to 12 months did not differ between the treatment groups and the placebo group: mean difference −8.34 (95% CI –25.93 to 9.26; p = .347) in the 10-day steroid group and −6.61 (−24.67 to 11.45; p = .467) in the 3-day steroid group, compared with placebo. Secondary outcomes showed no significant differences between groups. Corticosteroid treatments were well tolerated with no safety concerns.

Conclusions

Corticosteroid treatment does not significantly improve caloric recovery, vHIT gain recovery, or subjective well-being in patients with AUVP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesVestibular NeuronitisBetamethasoneHumansDouble-Blind MethodMaleMiddle AgedFemaleAdultAgedAcute DiseaseAged, 80 and overTreatment OutcomeYoung AdultAdolescentCaloric TestsSweden

Stichwörter der Autor:innen

acute unilateral vestibulopathycorticosteroid treatmentrandomized placebo-controlled trailsteroid treatmentvestibular neuritis

Substanzen

Adrenal Cortex HormonesBetamethasone

Autor:innen und Institutionen

  • Department of Clinical Sciences, Otorhinolaryngology Head and Neck Surgery, Skåne University Hospital, Lund University, Lund, Sweden.

ORCID-Profile: Julia Sjögren, Måns Magnusson, Fredrik Tjernström

Förderung

  • Swedish governmental clinical research, regional research support for clinical trials
  • Nils Gunnar Henrikssons fund

Zitieren

APA

Sjögren, J., Fransson, P. A., Magnusson, M., Karlberg, M., & Tjernström, F. (2025). Acute unilateral vestibulopathy and corticosteroid treatment - A randomized placebo-controlled double-blind trial. Journal of Vestibular Research. https://doi.org/10.1177/09574271241307649

Vancouver

Sjögren J, Fransson PA, Magnusson M, Karlberg M, Tjernström F. Acute unilateral vestibulopathy and corticosteroid treatment - A randomized placebo-controlled double-blind trial. Journal of Vestibular Research. 2025. doi:10.1177/09574271241307649

BibTeX
@article{Sjgren2025,
  author = {Sjögren, Julia and Fransson, Per-Anders and Magnusson, Måns and Karlberg, Mikael and Tjernström, Fredrik},
  title = {Acute unilateral vestibulopathy and corticosteroid treatment - A randomized placebo-controlled double-blind trial},
  journal = {Journal of Vestibular Research},
  year = {2025},
  doi = {10.1177/09574271241307649}
}
Kostenlos starten →